Efficacy News and Research

RSS
Cell-mediated immunity may be more important than neutralizing antibodies in COVID-19 outcome

Cell-mediated immunity may be more important than neutralizing antibodies in COVID-19 outcome

Researchers use fruit fly model to understand COVID-19-related neurological complications

Researchers use fruit fly model to understand COVID-19-related neurological complications

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

Early clinical data demonstrates the efficacy of existing drug in treating COVID-19

Early clinical data demonstrates the efficacy of existing drug in treating COVID-19

COVID-19 patients retain immunity against the virus for at least 8 months

COVID-19 patients retain immunity against the virus for at least 8 months

A hand-held device that measures aerosols could help prevent spread of COVID-19

A hand-held device that measures aerosols could help prevent spread of COVID-19

Immune-inflammatory mediators indicate that rejection and tissue injury can be avoided with drugs

Immune-inflammatory mediators indicate that rejection and tissue injury can be avoided with drugs

Nocturnal respiratory rate of heart patients can help predict the success of ICD treatment

Nocturnal respiratory rate of heart patients can help predict the success of ICD treatment

First patient enrolled in Phase II clinical trial of stem cell therapy for traumatic injuries

First patient enrolled in Phase II clinical trial of stem cell therapy for traumatic injuries

Effective vaccine strategies for New South Wales Australia under different vaccine supply

Effective vaccine strategies for New South Wales Australia under different vaccine supply

Smartphone fitness apps and wearable activity trackers boost physical activity levels

Smartphone fitness apps and wearable activity trackers boost physical activity levels

Invirsa signs license agreement with AWRI to expand treatment platform for respiratory diseases

Invirsa signs license agreement with AWRI to expand treatment platform for respiratory diseases

FDA approves first oral drug for treating adult patients with advanced prostate cancer

FDA approves first oral drug for treating adult patients with advanced prostate cancer

Study recommends blinded crossover and continued follow-ups to evaluate SARS-CoV-2 vaccine durability

Study recommends blinded crossover and continued follow-ups to evaluate SARS-CoV-2 vaccine durability

Review finds no consensus between researchers about why exercise works for chronic low back pain

Review finds no consensus between researchers about why exercise works for chronic low back pain

Novel device may help restore total eye function

Novel device may help restore total eye function

Study reveals innovative gene therapy approach to regenerate functional new neurons

Study reveals innovative gene therapy approach to regenerate functional new neurons

Fish oil supplements not associated with increases in  bad cholesterol

Fish oil supplements not associated with increases in bad cholesterol

Low-intensity pulsed ultrasound combined with microbubbles might enhance chemotherapy delivery

Low-intensity pulsed ultrasound combined with microbubbles might enhance chemotherapy delivery

Hepatitis C virus drugs synergize with remdesivir against SARS-CoV-2 in vitro

Hepatitis C virus drugs synergize with remdesivir against SARS-CoV-2 in vitro

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.